FDA OKs manufacturer’s version of Rice ventilator

An enhanced version of the ApolloBVM designed by Rice University engineers has received Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration as an emergency resuscitator for use during the COVID-19 pandemic. The device, as further developed by the Houston manufacturer Stewart & Stevenson Healthcare Technologies LLC, a subsidiary of Kirby Corporation, is designed to deliver air to the lungs of adult patients who require ventilation while they await the availability of a...

Bystander’ Cs meet their match in gene-editing technique

Biomolecular engineers at Rice University have found a C-worthy technique that dramatically enhances the accuracy of gene editing. The Rice lab of biomolecular engineer, Xue Sherry Gao, has introduced a set of tools that increase the accuracy of CRISPR-based edits in disease sequence models up to 6,000-fold compared with a current base editor, BE4max, that is considered state-of-the-art. Cytosine base editors are able to convert cytosines (C) to thymines (T) in the human genome, which...

Post-exposure antibody treatment protects those recently vaccinated against Ebola

With more widespread deployment of the Ebola vaccine to people living and working within hot zones, recently vaccinated people may encounter high-risk exposures to the virus before their body can develop the immunity needed to protect against infection. When a non-vaccinated person is exposed to Ebola virus, the most effective intervention currently available is an antibody treatment. But in someone who was recently vaccinated, experts have been concerned about the possibility of a harmful interaction...

Combination biomarker predicts response to immune checkpoint therapy in patients with advanced bladder cancer

In patients with metastatic bladder cancer, a novel combination of biomarkers from baseline tumor tissues was predictive of improved clinical responses and prolonged survival following treatment with immune checkpoint inhibitors, according to researchers from The University of Texas MD Anderson Cancer Center. The study used multi-platform analyses of tumor samples to discover that ARID1A mutations in tumor cells and expression of the immune signaling protein CXCL13 in surrounding immune cells were enriched in patients who...

UTMB researchers have discovered a new antiviral mechanism for dengue therapeutics

A multidisciplinary team from The University of Texas Medical Branch at Galveston has uncovered a new mechanism for designing antiviral drugs for dengue virus. Dengue virus is a very important mosquito-transmitted viral pathogen, causing 390 million human infections each year. Dengue is common in more than 100 countries and forty percent of the world’s population is at risk of infection. When someone becomes ill with dengue, symptoms that can range from mild to severe may...

‘Relaxed’ T cells critical to immune response

Like finding that needle in the haystack every time, your T cells manage what seems like an improbable task: quickly finding a few invaders among the many imposters in your body to trigger its immune response. T cells have to react fast and do so nearly perfectly to protect people from diseases. But first, they need a little “me” time. Rice University researchers suggest that has to do with how T cells “relax” in the...

Estrogen and testosterone therapies may decrease severity of COVID-19

Researchers from The University of Texas Medical Branch at Galveston explored the effects of estrogen and testosterone and their possible therapeutic effects in treating older patients with COVID-19. “Although there’s no specific therapies or vaccines available yet for COVID-19, reports have consistently shown that older adults and males are at increased risk of becoming severely ill or dying from COVID-19,” said Rasha Al-Lami, MD, Master of Clinical Science candidate in the UTMB department of Preventive...

Will COVID-19 shift long-term inpatient revenues for Texas hospitals?

By Alanna Moriarty, Content Marketing Manager, Definitive Healthcare   While many hospitals across the U.S. begin to recover from the worst of COVID-19 cases, healthcare industry leaders are raising questions about the long-term impacts of the pandemic on care delivery and patient outcomes. One key question is whether physicians will see increases in patient complication rates as a result of postponing care—both for patients delaying treatment for existing conditions and patients who put off seeking an initial diagnosis.  ...

Pandemic requires new ways of thinking about drug addiction, Baker Institute expert says

There is no shortage of articles offering advice for how to deal with lockdown: stick to a routine, get enough sleep, eat regular meals, maintain social connections at a safe distance, and so on.   Drug use often doesn’t make the list, but early signs suggest this is how many people are grappling with a dark and uncertain reality, according to an expert at Rice University’s Baker Institute for Public Policy.   “It will be...

Most Houstonians with symptoms are not being tested, according to Rice COVID-19 Registry

The vast majority of Houston-area residents who are experiencing symptoms consistent with COVID-19 are not getting tested for it, according to initial results of a survey from the COVID-19 Registry at Rice University.   In addition, more than 40% of households have lost income as a result of the crisis — and the economic impact appears to be much more severe among African American and Hispanic households than white and Asian American households. The initial...

MJH footer logo with red letters

Medical Journal – Houston is the leading source of healthcare business news. With extremely relevant content, late-breaking news and monthly exclusives from industry experts, MJH News has created a winning combination of must-read editorial that physicians and hospital executives eagerly anticipate month after month. MJH News is the resource that provides everything they need in one place, and it is a high honor that they rely upon Medical Journal – Houston to keep their practice or hospital on the cutting edge.

Archives